Did you get your copy of the
FenceBuilder Newsletter?

View the March - April 2022 Newsletter

View all Past Issues here

Cannabis as Medicine? Overview

It is utterly mind-blowing that people have no idea that Cannabis has been part of the medical prescription landscape for over 20 years. That’s right T. G. A (Therapeutic Goods Administration) trialled and approved cannabis based medicines have been available as an option to alleviate, if only in small ways, some of the symptoms of a couple of diseases or help with recovery from treatment. However, the claims of this plant being a ‘miracle cure’ for just about everything, have existed for of 100 years… yet in no credible and advanced research has any of the properties of the Cannabis plant ‘cured’ anything, ever!

There is no argument that some components of this incredibly complex plant can have some therapeutic benefit, be it ever so small, but deriving such from the plant with out co-opting some of the more detrimental components has proven incredibly difficult. On top of that, the evidence emerging from latest science, sees that some of these therapies, do more harm than good, with the temporary alleviating of a symptom on one hand, and incurring along term genetic harm on the other!

Again if facts and evidence matter to your best-practice health care, then this is the space for you. Make informed decisions based on science, and not quackery!

Wilson M. Compton, MD, MPE1Emily B. Einstein, PhD1

JAMA Netw Open. 2020;3(10):e2021067. doi:10.1001/jamanetworkopen.2020.21067

Consumer products containing cannabidiol (CBD) have markedly increased in popularity.1 Although many of these products are marketed in ways that may suggest potential effects on a variety of bodily functions, the precise health conditions that consumers believe they are treating with CBD products is uncertain. Is a consumer seeking a general wellness benefit, or are they attempting to treat a specific health condition? That is, is the consumer using CBD as a medication? If so, the US Food and Drug Administration (FDA) may have an important role to play in combatting unsupported claims of medical benefit. The article by Leas et al2 addresses this issue, and their analysis of user testimonials on the largest social media forum devoted to discussing CBD provides support for the idea that consumers are using products containing CBD to treat conditions that have FDA-approved, effective therapeutics. Although this finding is not unexpected given the substantial increase in sales and marketing of CBD-containing products,1 these data highlight a potential patient population that may be substituting CBD for evidence-based care.

Media portrayals of CBD as a health aid and a proliferation of products from cosmetics to candy that tout CBD as an ingredient contribute to the perception that CBD is a benign natural product.3 In addition, CBD is often cited as the component of cannabis that is nonpsychoactive likely because it does not contribute to the typical cannabis intoxication. Unlike Δ9-tetrahydrocannabinol (THC), CBD is a cannabinoid that does not make people high, and so this drug is not popular for recreational use. However, FDA approval of a CBD formulation to treat severe seizure disorders shows the capacity of CBD to alter brain activity. In addition, preclinical work shows that CBD has psychoactive properties based on its association with lessening the symptoms of such conditions as anxiety and addiction.4,5 Furthermore, CBD may also interact with medications or diminish their efficacy owing to its effects on components of drug metabolism.6 For these reasons, it is important that consumers understand that CBD should be regarded as a psychoactive chemical with multiple biological effects and is not just an uncomplicated dietary supplement.

A challenge to using evidence in the CBD debate, as Leas and colleagues2 suggest, is that the evidence base is still developing at a pace that is outstripped by the uptake of CBD. For instance, the study suggests that some persons with an addictive disorder are using CBD to treat their own condition. Such use of an unproven treatment could mean that effective treatments are not properly used; in some cases, this could result in serious harm.

For complete article

Also see Self-reported Cannabidiol (CBD) Use for Conditions With Proven Therapies

 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2771735

Featured Website

World Federation Against Drugs

World Federation Against Drugs (W.F.A.D) Dalgarno Institute is a member of this global initiative. For evidence based data on best practice drug policy in the global context.
Featured Website
Alt Tag

Institute for Behavior and Health

The Institute for Behavior and Health, Inc. is to reduce the use of illegal drugs. We work to achieve this mission by conducting research, promoting ideas that are affordable and scalable...
Featured Website

Drug Free Australia

Drug Free Australia Website. Drug Free Australia is a peak body, representing organizations and individuals who value the health and wellbeing of our nation...
Featured Website

Drug Advisory Council of Australia (D.A.C.A)

Drug Advisory Council of Australia (D.A.C.A) Dalgarno Institute is an executive member of this peak body. For updates on current illicit drug issues.
Featured Website

International Task Force on Strategic Drug Policy

(I.T.F.S.D.P) This international peak body continues to monitor and influence illicit drug policy on the international stage. Dalgarno Institute is a member organisation.
Featured Website

Smart Approaches to Marijuana

Smart Approaches to Marijuana. SAM's leaders are among the world's most prominent voices calling for science-based marijuana education and awareness.

21 Be There

There isn’t merely data sharing - it isn't about promoting a 'one dimensional' legislative solution to a complex problem
Featured Website

Drug Free Futures

Drug Policy Futures believes in engaging in an open dialogue about the strengths and weaknesses of global drug policies...
Featured Website

Action Alcohol

The National Alliance for Action on Alcohol is a national coalition of health and community organisations from across Australia that has been formed with the goal of reducing alcohol-related harm.
Featured Website

Greater Risk

Greater Risk Website - The younger they start the greater the risk...
Featured Website

Rivermend Health

RiverMend Health is a premier provider of scientifically driven, specialty behavioral health services to those suffering from alcohol and drug dependency, dual disorders, eating disorders, obesity and chronic pain.
Featured Website

Evidence-Based Practices Resource Center

SAMHSA is committed to improving prevention, treatment, and recovery support services for mental and substance use disorders.
Featured Website

SAMHSA

SAMHSA is committed to improving prevention, treatment, and recovery support services for mental and substance use disorders.